After a year of hard work, LATAM Bif-SOLACI has included over 700 patients! From SOLACI Research and the Registry Board of Directors we are glad to lead this important research initiative and we hope to keep growing in the coming months and be able to contribute with reliable data that will allow us to perfect...
We are glad to invite you to the opening of the SOLACI’s Complex Percutaneous Interventions Department (CHIP LATAM) that will take place on January 21 and 22, 2022. The activity has been divided into 2 modules of 4 hours a day and will feature over 25 keynote speakers and prestigious international guests who will be...
In patients at high risk of bleeding undergoing coronary PCI and after completing 3-month DAPT with no events, you may discontinue aspirin and follow up with ticagrelor monotherapy. This will significantly reduce bleeding without increasing ischemic events. With this strategy, the greater the risk of bleeding, the greater the absolute reduction of bleeding. Patients at...
During the virtual SOLACI-CACI 2021 Congress, the 11th ProEducar Fellows Course—SOLACI’s traditional activity aimed at expanding knowledge and providing didactic tools for all interventional trainees in Latin America—was held. The course was a huge success: almost 1500 people accessed the Andreas Gruentzig Virtual Room where the activity took place. Furthermore, over 35 prestigious speakers from all...
✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress. 👨🏫 Program: – SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy 01:06 – Optimal Medical Treatment in Patients with Cardiac Failure and Mitral Regurgitation – Florencia Renedo 12:12 – Ultrasonographic Screening of Patients for Endovascular Therapy – Walter García 25:43 –...
All the controlled randomized evidence recently published called for an updated document on antithrombotic management in transcatheter aortic valve replacement (TAVR). While thrombotic and hemorrhagic complications have diminished over time—as both the technique and the devices have been perfected—, they still remain as common adverse events in TAVR. Recommendations in the 2017 European Guidelines were...
SOLACI’s SOLidario Program took part in the XLII Regional SOLACI Sessions in Venezuela, where a charitable intervention was performed in collaboration with the Venezuelan Society of Interventional Cardiology (SOVECI) and Caracas University Hospital. In this opportunity, physicians treated a 60-year-old patient with significant heart disease under study for acute myocardial infarction after thrombolysis. Coronary angiography identified...
The latest figures show a lower number of emergency CABG for acute MI, and in turn increased primary PCI. The combination of surgeons not willing to take risks and interventional cardiologists empowered to treat practically any lesion has resulted in fewer patients receiving emergency CABG. Only a few years ago, interventional cardiologists at least had...
Here are the updated data from the Latin American Registry of Percutaneous Interventions in Coronary Bifurcations, corresponding to April 2021. We already have almost 300 patients enrolled! 3 For those who are still unfamiliar with it, the LATAM Bif Registry is a prospective, multicenter registry aiming at assessing the reality of percutaneous treatment of coronary...
Know the new data from The Latin American Registry of Coronary Bifurcation Percutaneous Intervention from March 2021. The registry is close to 250 patients (25% increase compared to the prior month) and continues to consolidate month after month. For those who are still unfamiliar with it, the LATAM Bif Registry is a prospective, multicenter registry...